Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen.

Mener A, Arthur CM, Patel SR, Liu J, Hendrickson JE, Stowell SR.

Front Immunol. 2018 Jun 11;9:676. doi: 10.3389/fimmu.2018.00676. eCollection 2018.

2.

Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion.

Sullivan HC, Arthur CM, Thompson L, Patel SR, Stowell SR, Hendrickson JE, Lazarus AH.

Transfusion. 2018 Feb;58(2):542-544. doi: 10.1111/trf.14452. No abstract available.

PMID:
29411397
3.

Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.

Patel SR, Bennett A, Girard-Pierce K, Maier CL, Chonat S, Arthur CM, Zerra PE, Mener A, Stowell SR.

Blood Adv. 2018 Jan 23;2(2):105-115. doi: 10.1182/bloodadvances.2017010124.

4.

Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A.

Zerra PE, Cox C, Baldwin WH, Patel SR, Arthur CM, Lollar P, Meeks SL, Stowell SR.

Blood. 2017 Dec 7;130(23):2559-2568. doi: 10.1182/blood-2017-05-782912. Epub 2017 Oct 4.

PMID:
28978569
5.

Daratumumab (anti-CD38) induces loss of CD38 on red blood cells.

Sullivan HC, Gerner-Smidt C, Nooka AK, Arthur CM, Thompson L, Mener A, Patel SR, Yee M, Fasano RM, Josephson CD, Kaufman RM, Roback JD, Lonial S, Stowell SR.

Blood. 2017 Jun 1;129(22):3033-3037. doi: 10.1182/blood-2016-11-749432. Epub 2017 Apr 3. No abstract available.

6.

Antigen Density Dictates Immune Responsiveness following Red Blood Cell Transfusion.

Arthur CM, Patel SR, Smith NH, Bennett A, Kamili NA, Mener A, Gerner-Smidt C, Sullivan HC, Hale JS, Wieland A, Youngblood B, Zimring JC, Hendrickson JE, Stowell SR.

J Immunol. 2017 Apr 1;198(7):2671-2680. doi: 10.4049/jimmunol.1601736. Epub 2017 Mar 1.

7.

Key regulators of galectin-glycan interactions.

Kamili NA, Arthur CM, Gerner-Smidt C, Tafesse E, Blenda A, Dias-Baruffi M, Stowell SR.

Proteomics. 2016 Dec;16(24):3111-3125. doi: 10.1002/pmic.201600116. Review.

8.

CD8+ T cells mediate antibody-independent platelet clearance in mice.

Arthur CM, Patel SR, Sullivan HC, Winkler AM, Tormey CA, Hendrickson JE, Stowell SR.

Blood. 2016 Apr 7;127(14):1823-7. doi: 10.1182/blood-2015-10-673426. Epub 2016 Jan 19.

9.

Innate immunity against molecular mimicry: Examining galectin-mediated antimicrobial activity.

Arthur CM, Patel SR, Mener A, Kamili NA, Fasano RM, Meyer E, Winkler AM, Sola-Visner M, Josephson CD, Stowell SR.

Bioessays. 2015 Dec;37(12):1327-37. doi: 10.1002/bies.201500055. Review.

PMID:
26577077
10.

Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model.

Stowell SR, Arthur CM, Girard-Pierce KR, Sullivan HC, Santhanakrishnan M, Natarajan P, Patel SR, Tormey CA, Zimring JC, Hendrickson JE.

Haematologica. 2015 Oct;100(10):e394-7. doi: 10.3324/haematol.2015.128603. Epub 2015 Jul 16. No abstract available.

11.

Evaluation of the bactericidal activity of galectins.

Arthur CM, Cummings RD, Stowell SR.

Methods Mol Biol. 2015;1207:421-30. doi: 10.1007/978-1-4939-1396-1_27.

12.

Detection of phosphatidylserine exposure on leukocytes following treatment with human galectins.

Arthur CM, Rodrigues LC, Baruffi MD, Sullivan HC, Cummings RD, Stowell SR.

Methods Mol Biol. 2015;1207:185-200. doi: 10.1007/978-1-4939-1396-1_12.

13.

Examining galectin binding specificity using glycan microarrays.

Arthur CM, Rodrigues LC, Baruffi MD, Sullivan HC, Heimburg-Molinaro J, Smith DF, Cummings RD, Stowell SR.

Methods Mol Biol. 2015;1207:115-31. doi: 10.1007/978-1-4939-1396-1_8.

14.

Alkylation of galectin-1 with iodoacetamide and mass spectrometric mapping of the sites of incorporation.

Stowell SR, Arthur CM, Cummings RD, Feasley CL.

Methods Mol Biol. 2015;1207:51-62. doi: 10.1007/978-1-4939-1396-1_3.

15.

Evolving mechanistic insights into galectin functions.

Arthur CM, Baruffi MD, Cummings RD, Stowell SR.

Methods Mol Biol. 2015;1207:1-35. doi: 10.1007/978-1-4939-1396-1_1. Review.

16.

Galatrox is a C-type lectin in Bothrops atrox snake venom that selectively binds LacNAc-terminated glycans and can induce acute inflammation.

Sartim MA, Riul TB, Del Cistia-Andrade C, Stowell SR, Arthur CM, Sorgi CA, Faccioli LH, Cummings RD, Dias-Baruffi M, Sampaio SV.

Glycobiology. 2014 Nov;24(11):1010-21. doi: 10.1093/glycob/cwu061. Epub 2014 Jun 27.

17.

Microbial glycan microarrays define key features of host-microbial interactions.

Stowell SR, Arthur CM, McBride R, Berger O, Razi N, Heimburg-Molinaro J, Rodrigues LC, Gourdine JP, Noll AJ, von Gunten S, Smith DF, Knirel YA, Paulson JC, Cummings RD.

Nat Chem Biol. 2014 Jun;10(6):470-6. doi: 10.1038/nchembio.1525. Epub 2014 May 11.

18.

Using glycan microarrays to understand immunity.

Arthur CM, Cummings RD, Stowell SR.

Curr Opin Chem Biol. 2014 Feb;18:55-61. doi: 10.1016/j.cbpa.2013.12.017. Epub 2014 Jan 29. Review.

19.

Antigen modulation confers protection to red blood cells from antibody through Fcγ receptor ligation.

Stowell SR, Liepkalns JS, Hendrickson JE, Girard-Pierce KR, Smith NH, Arthur CM, Zimring JC.

J Immunol. 2013 Nov 15;191(10):5013-25. doi: 10.4049/jimmunol.1300885. Epub 2013 Oct 9.

20.

A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation.

Girard-Pierce KR, Stowell SR, Smith NH, Arthur CM, Sullivan HC, Hendrickson JE, Zimring JC.

Blood. 2013 Sep 5;122(10):1793-801. doi: 10.1182/blood-2013-06-508952. Epub 2013 Jul 22.

Supplemental Content

Loading ...
Support Center